Clinical Trial Update: Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Phase 1]

View source ↗

Summary

A completed Phase 1 study evaluating thalidomide in patients with asymptomatic indolent non-Hodgkin lymphoma or chronic lymphocytic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Non-hodgkin Lymphoma

Drugs mentioned

• Thalomid (thalidomide) (thalidomide)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Leukemia, Lymphoma | Phase 1 | Status: COMPLETED